Bifikafusp alfa
Product Specifications
CAS Number
1957239-90-5
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
Bifikafusp alfa (L19-IL2) is an immunotherapeutic fusion protein combining human L19 antibodies with the cytokine interleukin 2 (IL2), targeting the extra domain B (EDB) of fibronectin, and has demonstrated anticancer activity [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15241017 1 Vial
Lentiviral mouse Il3 shRNA (UAS) - Lentiviral mouse Il3 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
136429 50 µg
SLC7A2 (Cationic Amino Acid Transporter 2, CAT-2, CAT2, Solute Carrier Family 7 Member 2, ATRC2)
Sign In for Pricing
View Details MBS6358300-01 0.2 mL
TRIM33, CT (TRIM33, KIAA1113, RFG7, TIF1G, E3 ubiquitin-protein ligase TRIM33, Ectodermin homolog, RET-fused gene 7 protein, Transcription intermediary factor 1-gamma, Tripartite motif-containing protein 33) (FITC)
Sign In for Pricing
View Details MBS6358300-02 5x 0.2 mL
TRIM33, CT (TRIM33, KIAA1113, RFG7, TIF1G, E3 ubiquitin-protein ligase TRIM33, Ectodermin homolog, RET-fused gene 7 protein, Transcription intermediary factor 1-gamma, Tripartite motif-containing protein 33) (FITC)
Sign In for Pricing
View Details sc-348927A 5 g
4-{[ (2,4-difluorophenyl) sulfonyl]amino}butanoic acid
Sign In for Pricing
View Details 